King Pharmaceuticals Inc Watch

from SC 13D/A ~50 pages Ex-1 Exchange Agreement

from S-3 ~20 pages Form of Underwriting Agreement

from SC 13G 1 page Joint Filing Agreement

from SC 13G 1 page <page> Exhibit 1 Joint Filing Agreement Waddell & Reed Financial, Inc., Waddell & Reed Financial Services, Inc., Waddell & Reed, Inc. and Waddell & Reed Investment Management Company (The "Filing Persons"), Hereby Agree to File Jointly a Schedule 13g and Any Amendments Thereto Relating to the Aggregate Ownership by Each of the Filing Persons of Any Voting Equity Security of a Class Which Is Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended, as Required by Rule 13d-1 and Rule 13d-2 Promulgated Under the Securities Exchange Act of 1934. Each of the Filing Persons Agrees That the Information Set Forth in Such Schedule 13g and Any Amendments Thereto With Respect to Such Filing Person Will Be True, Complete and Correct as of the Date of Such Schedule 13g or Such Amendment, to the Best of Such Filing Person's Knowledge and Belief, After Reasonable Inquiry. Each of the Filing Persons Makes No Representations as to the Accuracy or Adequacy of the Information Set Forth in the Schedule 13g or Any Amendments Thereto With Respect to Any Other Filing Person. Each of the Filing Persons Shall Promptly Notify the Other Filing Persons if Any of the Information Set Forth in the Schedule 13g or Any Amendments Thereto Shall Become Inaccurate in Any Material Respect or if Said Person Learns of Information That Would Require an Amendment to the Schedule 13g. in Witness Whereof, the Undersigned Have Set Their Hands This 17th Day of January, 2001. Waddell & Reed Financial, Inc. Waddell & Reed Financial Services, Inc. By: /S/ Daniel C. Schulte By: /S/ Wendy J. Hills Name: Daniel C. Schulte Name: Wendy J. Hills Title: Vice President Title: Attorney-In-Fact Waddell & Reed, Inc. Waddell & Reed Investment Management Company By: /S/ Wendy J. Hills By: /S/ Wendy J. Hills Name: Wendy J. Hills Name: Wendy J. Hills Title: Attorney-In-Fact Title: Attorney-In-Fact

from SC 13D ~10 pages Convertibile Note of Novavax, Inc.

from SC 13D/A 1 page <page> 1 Exhibit 1 to Schedule 13d Rule 13d-1(k)(1) Joint Filing Agreement in Accordance With Rule 13d-1(k)(1) Under the Securities Exchange Act of 1934, as Amended, the Undersigned Agree That for Purposes of Reports on Schedule 13d or Schedule 13g Relating to the Undersigneds' Holdings of Shares of the Common Stock, Without Par Value, of King Pharmaceuticals, Inc., Such Filings Shall Be Effected by a Single Joint Statement. in Witness Whereof, This Joint Filing Agreement Has Been Executed This 7th Day of November, 2000, by the Undersigned. /S/ Dennis M. Jones Dennis M. Jones Individually and as Trustee of the Dennis M. Jones Amended and Restated Revocable Trust Dated March 16, 1993 /S/ Judith A. Jones Judith A. Jones Individually and as Trustee of the Judith A. Jones Amended and Restated Revocable Trust Dated June 8, 1993

from S-3 ~20 pages Form of Underwriting Agreement

from S-1/A ~50 pages Form of Undewriting Agreement